CIK 0001601830
- Large accelerated filer
RECURSION PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RXRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464099738
- Phone
- +1 385-269-0203
- Business address
- 41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
- Former names
- Recursion Pharmaceuticals, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $701,222
- in 5 filings, $701K under 10b5-1 plans
Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-13 | Secora Michael Chief Financial Officer | Sale 10b5-1 | −25,000 | $9.93 | $248K | 805,413 |
| 2023-06-13 | Secora Michael Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −37,500 | 782,813 | ||
| 2023-06-07 | Gibson Christopher Chief Executive Officer | Exercise or conversion | +31,250 | $2.48 | $78K | 972,814 |
| 2023-06-07 | Gibson Christopher Chief Executive Officer | Sale | −56,436 | $9.05 | $511K | 916,378 |
| 2023-06-07 | Gibson Christopher Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −31,250 | 593,750 | ||
| 2023-06-02 | Virani Shafique Chief Business Officer | Sale 10b5-1 | −17,865 | $8.93 | $160K | 143,954 |
| 2023-06-01 | Mauro David J Chief Medical Officer | Grant or award | +190,713 | 190,713 | ||
| 2023-06-01 | Mauro David J Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +381,426 | 381,426 | ||
| 2023-06-01 | Virani Shafique Chief Business Officer | Sale 10b5-1 | −25,000 | $8.58 | $215K | 161,819 |
| 2023-05-31 | Larson Tina Marriott President and COO | Exercise or conversion | +3,000 | $1.06 | $3K | 427,160 |
| 2023-05-31 | Larson Tina Marriott President and COO | Sale | −3,000 | $8.63 | $26K | 424,160 |
| 2023-05-31 | Larson Tina Marriott President and COO | Exercise or conversion · Stock Option (Right to Buy) | −3,000 | 543,000 | ||
| 2023-05-30 | Borgeson Blake Director | Sale | −8,885 | $8.79 | $78K | 7,540,747 |
| 2023-05-16 | Borgeson Blake Director | Sale | −8,885 | $5.09 | $45K | 7,549,632 |
| 2023-05-15 | Virani Shafique Chief Business Officer | Shares withheld for taxes | −2,230 | $5.60 | $12K | 185,102 |
| 2023-05-15 | Larson Tina Marriott President and COO | Shares withheld for taxes | −5,415 | $5.60 | $30K | 422,429 |
| 2023-05-15 | Secora Michael Chief Financial Officer | Shares withheld for taxes | −4,760 | $5.60 | $27K | 790,159 |
| 2023-05-15 | Gibson Christopher Chief Executive Officer | Shares withheld for taxes | −11,661 | $5.60 | $65K | 941,564 |
| 2023-05-03 | Gibson Christopher Chief Executive Officer | Gift | −8,662 | 955,048 | ||
| 2023-05-03 | Gibson Christopher Chief Executive Officer | Conversion | +1,338 | 956,386 |
Page 39 of 41 · 805 trades